Related Experiment Video
Updated: Jun 18, 2025
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Targeting Autophagy in Atrial Fibrillation
Qiang Ye1, Wen Chen1, Hengsong Fu1
1Department of Cardiology, The Affiliated Hospital of Southwest Medical University, 646000 Luzhou, Sichuan, China.
Insights
Atrial fibrillation (AF) is a common heart rhythm disorder. Research suggests that regulating cellular autophagy may offer a new therapeutic target for reducing AF incidence.
Area of Science:
- Cardiology
- Cellular Biology
- Physiology
Background:
- Atrial fibrillation (AF) is the most prevalent clinical arrhythmia.
- Risk factors for AF include advanced age, hypertension, diabetes, and heart failure.
- The precise mechanisms underlying AF occurrence and persistence remain incompletely understood.
Purpose of the Study:
- To review the current research on the role of autophagy in atrial fibrillation (AF).
- To explore the potential of modulating autophagy as a therapeutic strategy for AF.
Main Methods:
- Literature review of recent studies on autophagy and AF.
- Analysis of the physiological and pathological roles of autophagy in cardiovascular disease.
- Synthesis of evidence linking autophagy dysregulation to AF pathophysiology.
Main Results:
- Autophagy, a fundamental cellular process, is implicated in cardiovascular diseases.
- Evidence suggests a connection between altered autophagy and the development and maintenance of AF.
- Modulating autophagy presents a promising avenue for AF treatment.
Conclusions:
- Autophagy plays a significant role in the pathophysiology of atrial fibrillation.
- Targeting autophagy pathways could be a novel therapeutic approach to manage and prevent AF.
- Further research is warranted to elucidate the specific mechanisms and optimize therapeutic interventions.
Abstract:
Atrial fibrillation (AF) is the most common type of arrhythmia in clinical practice, and its incidence is positively correlated with risk factors that include advanced age, hypertension, diabetes, and heart failure. Although our understanding of the mechanisms that govern the occurrence and persistence of AF has been increasing rapidly, the exact mechanism of AF is still not fully understood. Autophagy is an evolutionarily highly conserved and specific physiological process in cells that has been suggested as a potential therapeutic target for several cardiovascular diseases including the pathophysiology of AF. The present article provides an updated review of the fast-progressing field of research surrounding autophagy in AF, and how regulating autophagy might be a therapeutic target to reduce the incidence of AF.
